Evaluation of potential continuation rules for mepolizumab treatment of severe eosinophilic asthma. by Gunsoy, N, Cockle, S, Yancey, S, Keene, O, Bradford, E, Albers, F, Pavord, I

Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies. by Ortega, H, Yancey, S, Mayer, B, Gunsoy, N, Keene, O, Bleecker, E, Brightling, C, Pavord, I

Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma by Yancey, S, Ortega, H, Keene, O, Mayer, B, Gunsoy, N, Brightling, C, Bleecker, E, Haldar, P, Pavord, I